Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver

Carcinogenesis

Volumn 19, Issue 11, 1998, Pages 1989-1994

  Peters, Jeffrey M ^a   Aoyama, Toshifumi ^b   Cattley, Russell C ^c   Nobumitsu, Usuda ^b   Hashimoto, Takashi ^b   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; MESSENGER RNA; ONCOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; PROTEIN; PROTEIN P53; RECEPTOR SUBTYPE; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; LIVER; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN INDUCTION;

ACYL-COA OXIDASE; ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASES; LIVER NEOPLASMS; MALE; MICE; OXIDOREDUCTASES; PEROXISOME PROLIFERATORS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0031781381     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Lalwani, N.D., Reddy, M.K., Qureshi, S.A. and Reddy, J.K. (1981) Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis, 2, 645-650.
2. Reddy, J.K., Rao, S. and Moody, D.E. (1976) Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res., 36, 1211-1217.
3. Reddy, J.K., Rao, M.S., Azarnoff, D.L. and Sell, S. (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643), in rat and mouse liver. Cancer Res., 39, 152-161.
4. Auwerx, J. (1992) Regulation of gene expression by fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferator activated receptors. The Belgian Endocrine Society Lecture 1992. Horm. Res., 38, 269-277.
5. Wahli, W., Braissant, O. and Desvergne, B. (1995) Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol., 2, 261-266.
6. Reddy, J.K., Goel, S.K., Nemali, M.R. et al. (1986) Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl Acad. Sci. USA, 83, 1747-1751.
7. Aoyama, T., Souri, M., Kamijo, T., Ushikubo, S. and Hashimoto, T. (1994) Peroxisomal acyl-coenzyme A oxidase is a rate-limiting enzyme in a very-long-chain fatty acid beta-oxidation system. Biochem. Biophys. Res. Commun., 201, 1541-1547.
8. Hertz, R., Seckbach, M., Zakin, M.M. and Bar-Tana, J. (1996) Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem., 271, 218-224.
9. Motojima, K., Peters, J.M. and Gonzalez, F.J. (1997) PPAR alpha mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouse. Biochem. Biophys. Res. Commun., 230, 155-158.
10. Staels, B., Vu-Dac, N., Kosykh, V.A., Saladin, R., Fruchart, J.C., Dallongeville, J. and Auwerx, J. (1995) Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest., 95, 705-712.
11. Schoonjans, K., Staels, B. and Auwerx, J. (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res., 37, 907-925.
12. Aoyama, A., Peters, J.M., Iritani, N., Nasu-Nakajima, T., Furihata, K., Hashimoto, T. and Gonzalez, F.J. (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARα). J. Biol. Chem., 273, 5678-5684.
13. Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H. and Gonzalez, F.J. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol., 15, 3012-3022.
14. Peters, J.M., Cattley, R.C. and Gonzalez, F.J. (1997) Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis, 18, 2029-2033.
15. Reddy, J.K., Azarnoff, D.L. and Hignite, C.E. (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature, 283, 397-398.
16. Marsman, D.S., Cattley, R.C., Conway, J.G. and Popp, J.A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in rats. Cancer Res., 48, 6739-6744.
17. Marsman, D.S., Goldsworthy, T.L. and Popp, J.A. (1992) Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Carcinogenesis, 13, 1011-1017.
18. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheeldon, E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis, 16, 1693-1698.
19. Roberts, R.A. (1996) Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators. Ann. NY Acad. Sci., 804, 588-611.
20. Popp, J.A., Cattley, R.C., Miller, R.T. and Marsman, D.S. (1994) Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis. Prog. Clin. Biol. Res., 387, 193-207.
21. Ma, X., Stoffregen, D.A., Wheelock, G.D., Rininger, J.A. and Babish, J.G. (1997) Discordant hepatic expression of the cell division control enzyme p34cdc2 kinase, proliferating cell nuclear antigen, p53 tumor suppressor protein and p21Waf1 cyclin-dependent kinase inhibitory protein after Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid) dosing to rats. Mol. Pharmacol., 51, 69-78.
22. Rininger, J.A., Wheelock, G.D., Ma, X. and Babish, J.G. (1996) Discordant expression of the cyclin-dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643). Biochem. Pharmacol., 52, 1749-1755.
23. Rininger, J.A., Goldsworthy, T.L. and Babish, J.G. (1997) Time course comparison of cell-cycle protein expression following partial hepatectomy and Wy-14,643-induced hepatic cell proliferation in F344 rats. Carcinogenesis, 18, 935-941.
24. Gebel, T., Arand, M. and Oesch, F. (1992) Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver. FEBS Lett., 309, 37-40.
25. Osumi, T., Hashimoto, T. and Ui, N. (1980) Purification and properties of acyl-CoA oxidase from rat liver. J. Biochem., 87, 1735-1746.
26. Chapman, D.L. and Wolgemuth, D.J. (1992) Identification of a mouse B-type cyclin which exhibits developmentally regulated expression in the germ line. Mol. Reprod. Dev., 33, 259-269.
27. Factor, V.M., Kao, C.Y., Santoni-Rugiu, E., Woitach, J.T., Jensen, M.R. and Thorgeirsson, S.S. (1997) Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res., 57, 2089-2095.
28. Hamel, P.A. and Hanley-Hyde, J. (1997) G1 cyclins and control of the cell division cycle in normal and transformed cells. Cancer Invest., 15, 143-152.
29. Matsushime, H., Ewen, M.E., Strom, D.K., Kato, J.Y., Hanks, S.K., Roussel, M.F. and Sherr, C.J. (1992) Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell, 71, 323-334.
30. Th'ng, J.P., Wright, P.S., Hamaguchi, J., Lee, M.G., Norbury, C.J., Nurse, P. and Bradbury, E.M. (1990) The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell, 63, 313-324.
31. Shipman-Appasamy, P.M., Cohen, K.S. and Prystowsky, M.B. (1991) Nucleotide sequence of murine PCNA: interspecies comparison of the cDNA and the 5′ flanking region of the gene. DNA Seq., 2, 181-191.
32. Fan, C.Y., Pan, J., Chu, R. et al. (1996) Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acylcoenzyme A oxidase gene. J. Biol. Chem., 271, 24698-24710.
33. Nemali, M.R., Reddy, M.K., Usuda, N., Reddy, P.G., Comeau, L.D., Rao, M.S. and Reddy, J.K. (1989) Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol. Appl. Pharmacol., 97, 72-87.
34. Tugwood, J.D., Issemann, I. Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J., 11, 433-439.
35. Eacho, P.I., Lanier, T.L. and Brodhecker, C.A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of Wy-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis, 12, 1557-1561.
36. Roberts, R.A., Nebert, D.W., Hickman, J.A., Richburg, J.H. and Goldsworthy, T.L. (1997) Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundam. Appl. Toxicol., 38, 107-115.
37. Alder, H., Yoshinouchi, M., Prystowsky, M.B., Appasamy, P. and Baserga, R. (1992) A conserved region in intron 1 negatively regulates the expression of the PCNA gene. Nucleic Acids Res., 20, 1769-1775.
38. Chang, C.D., Ottavio, L., Travali, S., Lipson, K.E. and Baserga, R. (1990) Transcriptional and posttranscriptional regulation of the proliferating cell nuclear antigen gene. Mol. Cell Biol., 10, 3289-3296.
39. Nigg, E.A., Gallant, P. and Krek, W. (1992) Regulation of p34cdc2 protein kinase activity by phosphorylation and cyclin binding. Ciba Found. Symp., 170, 72-84.
40. Pines, J. (1994) The cell cycle kinases. Semin. Cancer Biol., 5, 305-313.
41. Albrecht, J.H., Hoffman, J.S., Kren, B.T. and Steer, C.J. (1993) Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases. Am. J. Physiol., 265, G857-864.
42. Furukawa, Y., Piwnica-Worms, H., Ernst, T.J., Kanakura, Y. and Griffin, J.D. (1990) cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science, 250, 805-808.
43. Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L. and Guguen-Guillouzo, C. (1994) Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J. Biol. Chem., 269, 2491-2500.
44. Bischoff, J.R., Friedman, P.N., Marshak, D.R., Prives, C. and Beach, D. (1990) Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl Acad. Sci. USA, 87, 4766-4770.
45. Chou, Y.H., Bischoff, J.R., Beach, D. and Goldman, R.D. (1990) Intermediate filament reorganization during mitosis is mediated by p34cdc2 phosphorylation of vimentin. Cell, 62, 1063-1071.
46. Dessev, G., Iovcheva-Dessev, C., Bischoff, J.R., Beach, D. and Goldman, R. (1991) A complex containing p34cdc2 and cyclin B phosphorylates the nuclear lamin and disassembles nuclei of clam oocytes in vitro. J. Cell Biol., 112, 523-533.
47. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
48. Keyomarsi, K. and Pardee, A.B. (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl Acad. Sci. USA, 90, 1112-1116.
49. Paradiso, A., Rabinovich, M., Vallejo, C. et al. (1996) p53 and PCNA expression in advanced colorectal cancer: response to chemotherapy and long-term prognosis. Int. J. Cancer. 69, 437-441.
50. Wang, A., Yoshimi, N., Ino, N., Tanaka, T. and Mori, H. (1997) Overexpression of cyclin B1 in human colorectal cancers. J. Cancer Res. Clin. Oncol., 123, 124-127.
51. Yasui, W., Ayhan, A., Kitadai, Y., Nishimura, K., Yokozaki, H., Ito, H. and Tahara, E. (1993) Increased expression of p34cdc2 and its kinase activity in human gastric and colonie carcinomas. Int. J. Cancer, 53, 36-41.
52. Dietrich, D.R. (1993) Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit. Rev. Toxicol., 23, 77-109.
53. Wolowiec, D., Deviller, P., Simonin, D., Souchier, C., Rimokh, R., Benchaib, M., Bryon, P.A. and Ffrench, M. (1995) Cdk1 is a marker of proliferation in human lymphoid cells. Int. J. Cancer, 61, 381-388.
54. Wang, T.C., Cardiff, R.D., Zukerberg, L., Lees, E., Arnold, A. and Schmidt, E.V. (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature, 369, 669-671.
55. Wu, C.G., Hakvoort, T.B., Lamers, W.H. and Chamuleau, R.A. (1996) Isolation of up- and down-regulated cDNAs associated with hepatocellular carcinoma by a subtraction-enhanced display technique. Biochim. Biophys. Acta, 1315, 169-175.
56. Wu, C.G., Boers, W., Reitsma, P.R., van Deventer, S.J. and Chamuleau, R.A. (1997) Overexpression of prothymosin alpha, concomitant with c-myc, during rat hepatic carcinogenesis. Biochem. Biophys. Res. Commun., 232, 817-821.
57. Wu, C.G., Groenink, M., Bosma, A., Reitsma, P.H., van Deventer, S.J. and Chamuleau, R.A. (1997) Rat ferritin-H: cDNA cloning, differential expression and localization during hepatocarcinogenesis. Carcinogenesis, 18, 47-52.
58. Miller, R.T., Glover, S.E., Stewart, W.S., Corton, J.C., Popp, J.A. and Cattley, R.C. (1996) Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator Wy-14,643. Carcinogenesis, 17, 1337-1341.
59. Miller, R.T., Cattley, R.C., Marsman, D.S., Lyght, O. and Popp, J.A. (1995) TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Carcinogenesis, 16, 77-82.
60. Packham, G. and Cleveland, J.L. (1995) c-myc and apoptosis. Biochim. Biophys. Acta, 1242, 11-28.
61. Packham, G., Porter, C.W. and Cleveland, J.L. (1996) c-myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene, 13, 461-469.
62. Bojes, H.K., Germolec, D.R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M.I. and Thurman, R.G. (1997) Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, Wy-14,643. Carcinogenesis, 18, 669-674.
63. Rose, M.L., Germolec, D.R., Schoonhoven, R. and Thurman, R.G. (1997) Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis, 18, 1453-1456.